| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/03/2004 | US6770673 Administering dimethylaminoarglabin or salt as antitumor agent |
| 08/03/2004 | US6770650 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/03/2004 | US6770649 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/03/2004 | US6770648 Antidiabetic agents |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | CA2222282C Process and compositions for the recovery of ascorbic acid |
| 07/29/2004 | WO2004063187A1 Substituted benzoyl derivatives uses as herbicides |
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063129A2 Methods for nucleophilic fluoromethylation |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004047743A3 1-aryl-2-hydroxyethyl amides as potassium channel openers |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | US20040147775 Process for the synthesis of 3.3A.6.6A-tetrahydro-2H-cyclopentan[b]furan-2-one |
| 07/29/2004 | US20040147758 Compounds for treatment of AIDS with enzyme inhibitors |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147592 Production and use of derivatized homoserine lactones |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147515 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 07/29/2004 | US20040147507 Compositions useful as inhibitors of JAK and other protein kinases |
| 07/29/2004 | US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis |
| 07/29/2004 | US20040147454 Aspartyl protease inhibitors |
| 07/29/2004 | US20040146449 Decomposition or chemical reaction of liquid precursors; chromatography, extraction or impregnation/modification of solid substrates |
| 07/29/2004 | DE10303311A1 Production of di-, oligo- and polymers of dicarbonyl compounds as aqueous formulation or powder, used for tanning and as preservative, involves acid-catalyzed condensation of 2-substituted heterocyclic compound in water |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/28/2004 | EP1441224A2 Enzyme inhibition immunoassay |
| 07/28/2004 | EP1440691A2 Treatment of neurotic disorders |
| 07/28/2004 | EP1440690A2 Treatment of neurotic disorders |
| 07/28/2004 | EP1440689A2 Treatment of neurotic disorders |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1137632B1 Thiourea inhibitors of herpes viruses |
| 07/28/2004 | EP1036071B1 Syntheses of 5,5'-diformyl-2-2'difuran and derivatives thereof |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1515564A Method for preparing sitaipulan |
| 07/28/2004 | CN1159307C Method for preparing xitaipulan |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159276C Process for prond. of tetrahydrofuran, gammabutyrolactone and butanediol |
| 07/27/2004 | US6768024 Triamine derivative melanocortin receptor ligands and methods of using same |
| 07/27/2004 | US6768011 Antidepressants; reacting 3-(4-fluoro-), 6-cyanoisobenzofuranwith alkylation agent |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004060987A2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 07/22/2004 | WO2004060895A1 Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004037879A3 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom |
| 07/22/2004 | WO2004029045A3 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 07/22/2004 | WO2004026253A3 Novel lapacho compounds and methods of use thereof |
| 07/22/2004 | WO2004023872A3 High concentration topical insecticide |
| 07/22/2004 | WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/22/2004 | WO2003078310A3 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen |
| 07/22/2004 | US20040143141 Process for production of dimers of aromatic monohydroxyl compounds |
| 07/22/2004 | US20040143135 liquid-phase oxidizing 2,4,5-trimethylbenzaldehyde in water with molecular oxygen; recrystallized mother liquor separated recycled to oxidation step after part of the water is removed; bromine compound and heavy metal compound catalysts |
| 07/22/2004 | US20040143123 zirconium complexes of bis(o-hydroxybenzylamines); further reaction of dicarbonyls such as methyl (2S)-5-chloro-2,3-dihydro-2-hydroxy-1-oxo-1H-indene-2-carboxylate with protected hydrazine and N-(XC(O))-N-methoxycarbonyl-p-(trifluoromethyl)aniline |
| 07/22/2004 | US20040143016 Catalytic antioxidants and methods of use |
| 07/22/2004 | US20040143006 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142980 Viricides; hepatitis virus infections |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | DE202004003714U1 New phenyl maleic anhydride and maleimide derivatives used for lowering blood pressure, increasing high-density lipoprotein or as central cholinergic agonists, hepatoprotective, antiinflammatory agents and antitumor agents |
| 07/22/2004 | DE10301110A1 Substituierte Benzoylderivate als Herbizide Substituted benzoyl derivatives as herbicides |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439172A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1439165A1 Abscisic acid biosynthesis inhibitor |
| 07/21/2004 | EP1439161A2 Production method of pyromellitic acid and pyromellitic anhydride |
| 07/21/2004 | EP1439160A2 Solid phase synthesis of salts of organic acids including butyric acid |
| 07/21/2004 | EP1439157A2 Method for producing Suzuki coupling compound catalysed by a nickel compound |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438349A1 Triarylamine containing monomers for optoelectronic devices |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438040A1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 07/21/2004 | EP1154981B1 Liquid crystal compounds |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1513848A Method of extracting phenolic components from chinese medicine red sage root and its freeze dried powder injection agent |
| 07/21/2004 | CN1513829A Method of preparing cyclopropane carbaxglic acid and its intermadiate |
| 07/21/2004 | CN1158271C Method for preparation of 5-cyano-2-benzo [C] furanone |
| 07/21/2004 | CN1158244C Process for preparing R-(-)-carnitine from S-(-)-chlorosuccinic acid or derivative thereof |
| 07/21/2004 | CN1158233C Process for prepn. of butanediol ,butyrolactone and tetrahydrofuran |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/20/2004 | CA2267153C Synthesis of aryl ethers, methods and reagents related thereto |
| 07/20/2004 | CA2096326C 3-(acyloxyphenyl)benzofuran-2-one stabilisers |
| 07/20/2004 | CA2079703C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |